Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used in PET or SPECT imaging. This includes advances in myocardiac perfusion agents.

cyclone 70 zevacor IBM nuclear imaging radiopharmaceuticals and tracers PET
News | November 08, 2013
November 8, 2013 — Zevacor Molecular, a healthcare firm that manufactures and distributes...
Vizamyl, flutemetamol, FDA, GE

Vizamyl (flutemetamol F-18) uptake shown in brains of patients who are normal and full of amyloid plaque.

Technology | October 25, 2013
October 25, 2013 — The U.S. Food and Drug Administration (FDA) today approved Vizamyl (flutemetamol F 18 injection), a...
nuclear imaging PET systems radiopharmaceuticals alzheimer's association
News | October 03, 2013

October 3, 2013 — The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (...

nuclear imaging clinical trial study radiopharmaceuticals tracers li-cor
News | October 02, 2013

October 2, 2013 —The Thayer School of Engineering and Geisel School of Medicine at Dartmouth together with LI-COR...

News | September 26, 2013

September 26, 2013 — Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to...

News | September 03, 2013

September 3, 2013 — Navidea Biopharmaceuticals Inc., a biopharmaceutical company focused on precision diagnostic...

News | August 09, 2013

August 9, 2013 — Positron Corporation entered into a multi-year radioisotope supply agreement with iThemba LABS of...

News | August 08, 2013

The Centers for Medicare and Medicaid Services (CMS) released its proposed decision memorandum regarding the use of...

Feature | July 26, 2013 | Jamshid Maddahi, M.D., FACC, FASNC, and René R. S. Packard, M.D.
Coronary artery disease (CAD) is a major cause of death in modern industrialized countries. Assessments of regional...
PET vs. SPECT, nuclear imaging advances with BFPET

BFPET demonstrates higher resolution in the evaluation of myocardial perfusion in this series of images contrasting the results of a PET scan done with FluoroPharma's fluorine-18 based agent and a SPECT study done with sestamibi. Images were captured during an investigator-initiated study of BFPET conducted at 301 Hospital in Beijing, China.

Feature | Nuclear Imaging | July 23, 2013 | Dave Fornell

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (...

Biopharmaceuticals Inc. Clinical Study Alzheimer's Beta Amyloig
Feature | July 12, 2013

July 12, 2013 — Biopharmaceuticals Inc. announced the first subject has been enrolled in its NAV4694 global, pivotal...

SNMMI Alzheimer's Association Medicare Decision CMS Beta Amyloid PET Coverage
Feature | July 11, 2013

July 11, 2013 — The Society of Nuclear Medicine and...

Feature | June 20, 2013

June 20, 2013 – No matter where they have hidden, metastatic prostate cancer cells still express some of the same...

Feature | June 20, 2013

June 20, 2013 — A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon...

News | June 19, 2013

June 19, 2013 — Alzheimer’s disease has been linked in many studies to amyloid plaque buildup in the brain, but new...

News | June 19, 2013

June 19, 2013 — By targeting both bone cell activity and immune response and improving imaging data interpretation,...

News | June 17, 2013

June 17, 2013 — Accurate estimation of radiation absorbed dose in radioimmunotherapy (RIT) based on state-of-the-art...